Literature DB >> 9452490

A cytosolic, galphaq- and betagamma-insensitive splice variant of phospholipase C-beta4.

M J Kim1, D S Min, S H Ryu, P G Suh.   

Abstract

Phospholipase C (PLC)-beta4 has been considered to be a mammalian homolog of the NorpA PLC, which is responsible for visual signal transduction in Drosophila. We reported previously the cloning of a cDNA encoding rat phospholipase C-beta4 (PLC-beta4) (Kim, M. J., Bahk, Y. Y., Min, D. S., Lee, S. J., Ryu, S. H., and Suh, P.-G. (1993) Biochem. Biophys. Res. Commun. 194, 706-712). We report now the isolation and characterization of a splice variant (PLC-beta4b). PLC-beta4b is identical to the 130-kDa PLC-beta4 (PLC-beta4a) except that the carboxyl-terminal 162 amino acids of PLC-beta4a are replaced by 10 distinct amino acids. The existence of PLC-beta4b transcripts in the rat brain was demonstrated by reverse transcription-polymerase chain reaction analysis. Immunological analysis using polyclonal antibody specific for PLC-beta4b revealed that this splice variant exists in rat brain cytosol. To investigate functional differences between the two forms of PLC-beta4, transient expression studies in COS-7 cells were conducted. We found that PLC-beta4a was localized mainly in the particulate fraction of the cell, and it could be activated by Galphaq, whereas PLC-beta4b was localized exclusively in the soluble fraction, and it could not be activated by Galphaq. In addition, both PLC-beta4a and PLC-beta4b were not activated by G-protein betagamma-subunits purified from rat brain. These results suggest that PLC-beta4b may be regulated by a mechanism different from that of PLC-beta4a, and therefore it may play a distinct role in PLC-mediated signal transduction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452490     DOI: 10.1074/jbc.273.6.3618

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Structural insights into phospholipase C-β function.

Authors:  Angeline M Lyon; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2013-07-23       Impact factor: 4.436

2.  Differential distribution of phospholipase C beta isoforms and diaglycerol kinase-beta in rodents cerebella corroborates the division of unipolar brush cells into two major subtypes.

Authors:  Gabriella Sekerková; Masahiko Watanabe; Marco Martina; Enrico Mugnaini
Journal:  Brain Struct Funct       Date:  2013-03-16       Impact factor: 3.270

Review 3.  Phosphoinositide-specific phospholipase C in health and disease.

Authors:  Lucio Cocco; Matilde Y Follo; Lucia Manzoli; Pann-Ghill Suh
Journal:  J Lipid Res       Date:  2015-03-27       Impact factor: 5.922

4.  Phospholipase C beta3 is a key component in the Gbetagamma/PKCeta/PKD-mediated regulation of trans-Golgi network to plasma membrane transport.

Authors:  Alberto M Díaz Añel
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

5.  Phospholipase Cbeta4 isozyme is expressed in human, rat, and murine heart left ventricles and in HL-1 cardiomyocytes.

Authors:  David Otaegui; Ramón Querejeta; Ander Arrieta; Ane Lazkano; Angel Bidaurrazaga; Jose Ramón Arriandiaga; Pablo Aldazabal; Mikel Asier Garro
Journal:  Mol Cell Biochem       Date:  2009-10-24       Impact factor: 3.396

Review 6.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

7.  Angiotensin II Reduces Lipoprotein Lipase Expression in Visceral Adipose Tissue via Phospholipase C β4 Depending on Feeding but Increases Lipoprotein Lipase Expression in Subcutaneous Adipose Tissue via c-Src.

Authors:  Tsuyoshi Uchiyama; Shoichi Tomono; Koichi Sato; Tetsuya Nakamura; Masahiko Kurabayashi; Fumikazu Okajima
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

8.  Phospholipase C-β1 and β4 contribute to non-genetic cell-to-cell variability in histamine-induced calcium signals in HeLa cells.

Authors:  Sachiko Ishida; Toru Matsu-Ura; Kiyoko Fukami; Takayuki Michikawa; Katsuhiko Mikoshiba
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.